Company intelligence / Profile preview

Mohave Services

San Carlos, California, United Stateshdshawks.org ↗

Ownership: Private
Development stage: Other

Overview

Mojave Bio has developed AmberGlass technology to automate and standardize workflows in biopharmaceutical manufacturing and cell therapy medicine. Their proprietary process encapsulates biologic reagents—such as antibodies, enzymes, nucleic acids—in a stable glass-like matrix that preserves integrity at room temperature for years. This enables ready-to-use assay kits that simplify QA/QC labs, clinical trials reagent supply chains, and bioreactor growth factor delivery.

Modalities: AntibodyEnzymeNucleic acidCell-based reagents
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Mohave Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mohave Services.

Explore the full profile